Bio-Rad Labs Inc. A buy Royal Bank of Canada
Start price
02.05.25
/
50%
€209.20
Target price
02.05.26
€347.08
Performance (%)
4.16%
Price
09:27
€217.90
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 4.16%. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Rad Labs Inc. A | 4.400% | 4.400% |
| iShares Core DAX® | -1.165% | -0.351% |
| iShares Nasdaq 100 | 1.585% | 4.605% |
| iShares Nikkei 225® | 1.992% | -2.018% |
| iShares S&P 500 | 2.158% | 4.638% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Royal Bank of Canada from $409.00 to $392.00. They now have an "outperform" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€331.60
14.01.25
14.01.25
€467.48
14.01.26
14.01.26
-34.29%
09:27
09:27
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€315.50
09.12.24
09.12.24
€454.64
09.12.25
09.12.25
-30.94%
09:27
09:27
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€329.60
31.10.24
31.10.24
€431.06
31.10.25
31.10.25
-33.89%
09:27
09:27
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€292.30
16.08.24
16.08.24
€364.63
16.08.25
16.08.25
-26.14%
09:27
09:27
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€307.80
02.08.24
02.08.24
€367.36
02.08.25
02.08.25
-29.21%
09:27
09:27
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€445.58
16.02.25
16.02.25
-15.75%
17.02.25
17.02.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€363.40
04.08.23
04.08.23
€474.64
04.08.24
04.08.24
-17.06%
05.08.24
05.08.24